COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00162630
Recruitment Status : Completed
First Posted : September 13, 2005
Last Update Posted : September 15, 2006
IMK Fonden
Information provided by:
Hvidovre University Hospital

Brief Summary:
To evaluate the analgesic potential of an neural blockade (Fascia iliaca compartment) with local anaesthetics in patients with hip fracture immediately after arrival in the emergency department.

Condition or disease Intervention/treatment Phase
Hip Fracture Procedure: Fascia Iliaca Compartment Blockade Phase 4

Detailed Description:
Hip fracture patients have severe pain in the acute phase. Traditional analgesic treatment have consisted of intramuscular morphine with its associated side effects. The trial evaluates the Fascia iliaca compartment compared to regular opioid pain therapy in hip fracture patinets immediately after arrival at the emergency department.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase
Study Start Date : May 2003
Study Completion Date : March 2006

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Pain relief within 3 hours

Secondary Outcome Measures :
  1. Nausea
  2. Pain on transfer
  3. Discomfort with block placement

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Primary hip fracture suspected
  • able to give informed consent
  • no substance abuse
  • no regular opioid therapy
  • no opioid treatment within the last 6 hours
  • morphine intolerance
  • allergies to local anaesthetics

Exclusion Criteria:

  • Fracture ruled out on x-ray

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00162630

Layout table for location information
Hvidovre University Hospital
Hvidovre, Denmark, 2650
Sponsors and Collaborators
Hvidovre University Hospital
IMK Fonden
Layout table for investigator information
Study Director: Nicolai B Foss, MD Hvidovre University Hospital
Layout table for additonal information Identifier: NCT00162630    
Other Study ID Numbers: HHSG-rct-04
First Posted: September 13, 2005    Key Record Dates
Last Update Posted: September 15, 2006
Last Verified: September 2006
Keywords provided by Hvidovre University Hospital:
Hip fracture, pain, regional anaesthesia, analgesia
Additional relevant MeSH terms:
Layout table for MeSH terms
Fractures, Bone
Hip Fractures
Wounds and Injuries
Femoral Fractures
Hip Injuries
Leg Injuries